Trimodality therapy for mediastnoscopic N2-positive non-small cell lung cancer

被引：0

作者：

Ahn, Y ^{[1
]}

Kang, M ^{[1
]}

Nam, H ^{[1
]}

Oh, D ^{[1
]}

Park, Y ^{[1
]}

Lim, D ^{[1
]}

Park, K ^{[1
]}

Shim, Y ^{[1
]}

Kwon, O ^{[1
]}

机构：

[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea

来源：

LUNG CANCER | 2005年 / 49卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S165 / S165

页数：1

共 50 条

[1] Trimodality Therapy in the Treatment of Stage III N2-Positive Non-Small Cell Lung Cancer: A National Cancer Database Analysis
Behera, Madhusmita
Steuer, Conor E.
Liu, Yuan
Fernandez, Felix
Fu, Chao
Higgins, Kristin A.
Gillespie, Theresa W.
Pakkala, Suchita
Pillai, Rathi N.
Force, Seth
Belani, Chandra P.
Khuri, Fadlo R.
Curran, Walter J.
Ramalingam, Suresh S.
ONCOLOGIST, 2020, 25 (06): : E964 - E975
[2] Adjuvant therapy following induction therapy and surgery improves survival in N2-positive non-small cell lung cancer
White, Abby A.
Lee, Daniel N.
Mazzola, Emanuele
Kucukak, Suden
Polhemus, Emily
Jaklitsch, Michael T.
Mentzer, Steven J.
Wee, Jon O.
Bueno, Raphael
Swanson, Scott J.
JOURNAL OF SURGICAL ONCOLOGY, 2021, 123 (02) : 579 - 586
[3] Pretreatment Clinical Mediastinal Nodal Bulk and Extent do not Influence Survival in N2-Positive Stage IIIA Non-small Cell Lung Cancer Patients Treated with Trimodality Therapy
Hyebin Lee
Yong Chan Ahn
Hongryull Pyo
BoKyong Kim
Dongryul Oh
Heerim Nam
Eunju Lee
Jong-Mu Sun
Jin Seok Ahn
Myung-Ju Ahn
Keunchil Park
Yong Soo Choi
Jhingook Kim
Jae Ill Zo
Young Mog Shim
Annals of Surgical Oncology, 2014, 21 : 2083 - 2090
[4] Pretreatment Clinical Mediastinal Nodal Bulk and Extent do not Influence Survival in N2-Positive Stage IIIA Non-small Cell Lung Cancer Patients Treated with Trimodality Therapy
Lee, Hyebin
Ahn, Yong Chan
Pyo, Hongryull
Kim, BoKyong
Oh, Dongryul
Nam, Heerim
Lee, Eunju
Sun, Jong-Mu
Ahn, Jin Seok
Ahn, Myung-Ju
Park, Keunchil
Choi, Yong Soo
Kim, Jhingook
Zo, Jae Ill
Shim, Young Mog
ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (06) : 2083 - 2090
[5] Trimodality therapy for locally advanced non-small cell lung cancer
Lackner, R. P.
Ganti, A.
Zhen, W.
Copur, M. S.
Vaziri, I. A.
Bolton, M.
Hlavaty, T.
Trujillo, K. P.
Kessinger, M. A.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[6] Postoperative chemotherapy as effective as preoperative for N2-positive stage III non-small cell lung cancer.
Boffa, Daniel J.
Hancock, Jacquelyn
Moreno, Amy
Rosen, Joshua
Kim, Anthony W.
Detterbeck, Frank C.
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[7] Is trimodality approach better then bimodality in stage IIIA, N2 positive non-small cell lung cancer?
Park, Byeong-Bae
Park, Joon Oh
Kim, Hojoong
Ahn, Yong Chan
Choi, Yong Soo
Kim, Kwhanmien
Kim, Jhingook
Shim, Young Mog
Ahn, Jin Seok
Park, Keunchil
LUNG CANCER, 2006, 53 (03) : 323 - 330
[8] Definitive Bimodality Concurrent Chemoradiotherapy in Patients with Inoperable N2-positive Stage IIIA Non-small Cell Lung Cancer
Noh, Jae Myoung
Ahn, Yong Chan
Lee, Hyebin
Pyo, Hongryull
Kim, BoKyong
Oh, Dongryul
Park, Hyojung
Lee, Eonju
Park, Keunchil
Ahn, Jin Seok
Ahn, Myung-Ju
Sun, Jong-Mu
CANCER RESEARCH AND TREATMENT, 2015, 47 (04): : 645 - 652
[9] Adjuvant Chemoradiotherapy vs. Chemotherapy for Completely Resected Unsuspected N2-Positive Non-Small Cell Lung Cancer
Sun, J.
Kim, H. K.
Lee, S.
Ahn, Y. C.
Kim, J.
Ahn, M.
Zo, J. I.
Shim, Y. M.
Park, K.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2014 - S2014
[10] Early recurrence of completely resected N2-positive non-small-cell lung cancer
Tsukioka T.
Nishiyama N.
Iwata T.
Izumi N.
Mizuguchi S.
Morita R.
Inoue K.
Suehiro S.
General Thoracic and Cardiovascular Surgery, 2007, 55 (3) : 113 - 118

← 1 2 3 4 5 →